Anne Hagemeijer

Title: The Innovations of Anne Hagemeijer

Introduction

Anne Hagemeijer is a notable inventor based in Pellenberg, Belgium. She has made significant contributions to the field of oncology, particularly in the development of methods related to T-cell acute lymphoblastic leukemia. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Hagemeijer's latest patents focus on an episomal fusion gene. The first patent describes an episomal structure that expresses a functional oncogene, specifically a fusion gene of two chromosomal gene fragments. This invention relates to the NUP214-ABL1 fusion product, which is crucial in the development of T-cell acute lymphoblastic leukemia. The patent also outlines methods to detect this fusion and strategies to prevent the oncogenic activity associated with it.

Career Highlights

Throughout her career, Anne has worked with reputable organizations such as Vib Vzw and KU Leuven Research & Development. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Jan Cools and Peter Marynen. Their collaborative efforts have further advanced the research and development of innovative solutions in oncology.

Conclusion

Anne Hagemeijer is a pioneering inventor whose work in the field of oncology has the potential to impact the lives of many. Her contributions through her patents and collaborations highlight her dedication to advancing medical science.